ITM to Host Symposium on Actinium-225 Targeted Radionuclide
Garching / Munich, June 15, 2022 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host an industry-sponsored lunch symposium on Targeted ...